Recombinant Human OX40/TNFRSF4/CD134 Protein(C-Fc)
Cat#:TP04732应用:Positive Control; Immunogen; SDS-PAGE; WB
Product Name: | CD134/OX40L receptor Rabbit pAb |
Cat No.: | DPA01830 |
Clonality: | Polyclonal |
Species Reactivity: | Human |
Tested Applications: | WB,IHC,ICC/IF,FC,IP |
Recommended Dilution: | WB: 1:1000 IHC: 1:500 ICC/IF: 1:20 FC: 1:50 IP: 1:20 |
Size: | 30ul 50ul 100uL |
Format: | Liquid |
Source: | Rabbit |
Purification Method: | Affinity Purification |
Isotype: | IgG |
Conjugate: | Un-conjugated |
Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
Immunogen: | A synthetic peptide of human CD134/OX40L receptor |
Calculated Molecular Weight: | 29 kDa |
Observed Molecular Weight: | 29,45 kDa |
GenBank Accession Number: | P43489 |
Gene ID (NCBI): | 7293 |
Synonyms: | OX40; ACT35; CD134; IMD16; TXGP1L |
Background: | The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation. [provided by RefSeq, Jul 2008] |
Category: | Primary Ab |